IL-30 (IL-27A): a familiar stranger in immunity, inflammation, and cancer

Exp Mol Med. 2021 May;53(5):823-834. doi: 10.1038/s12276-021-00630-x. Epub 2021 May 28.

Abstract

Over the years, interleukin (IL)-27 has received much attention because of its highly divergent, sometimes even opposing, functions in immunity. IL-30, the p28 subunit that forms IL-27 together with Ebi3 and is also known as IL-27p28 or IL-27A, has been considered a surrogate to represent IL-27. However, it was later discovered that IL-30 can form complexes with other protein subunits, potentially leading to overlapping or discrete functions. Furthermore, there is emerging evidence that IL-30 itself may perform immunomodulatory functions independent of Ebi3 or other binding partners and that IL-30 production is strongly associated with certain cancers in humans. In this review, we will discuss the biology of IL-30 and other IL-30-associated cytokines and their functions in inflammation and cancer.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cytokines / metabolism
  • Disease Models, Animal
  • Disease Susceptibility
  • Gene Expression Regulation
  • Humans
  • Immunity*
  • Inflammation / etiology*
  • Inflammation / metabolism*
  • Inflammation / pathology
  • Interleukins / chemistry
  • Interleukins / genetics*
  • Interleukins / metabolism*
  • Neoplasms / etiology*
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Protein Multimerization
  • Signal Transduction

Substances

  • Cytokines
  • Interleukins
  • MYDGF protein, human